{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:55:53Z","timestamp":1795110953115,"version":"4.10.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctoral Fellowship Program","award":["GZC20232435"],"award-info":[{"award-number":["GZC20232435"]}]},{"name":"Medical Science and Technology Research Project of Henan Province","award":["252102311163"],"award-info":[{"award-number":["252102311163"]}]},{"name":"National Natural Science Foundation of China Joint Fund Key Support Project","award":["U24A20734"],"award-info":[{"award-number":["U24A20734"]}]},{"name":"Key Special Project for International Science and Technology Innovation Cooperation between Governments under the National Key R&D Program","award":["2022YFE0141000"],"award-info":[{"award-number":["2022YFE0141000"]}]},{"name":"National Natural Science Foundation of China\u2013General Project","award":["82272873"],"award-info":[{"award-number":["82272873"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04180-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:01:08Z","timestamp":1759129268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Single-cell transcriptomic analyses provide insights into SPP1+ TAM-mediated immune suppression and CD8+ T cell dysfunction in lung cancer"],"prefix":"10.1007","volume":"74","author":[{"given":"Rahma Taher","family":"Almgrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qitai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"6","key":"4180_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"10066","key":"4180_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR et al (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389(10066):299\u2013311. https:\/\/doi.org\/10.1016\/S0140-6736(16)30958-8","journal-title":"Lancet"},{"key":"4180_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2018.02.003","volume":"421","author":"Y Zhang","year":"2018","unstructured":"Zhang Y et al (2018) Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancer. Cancer Lett 421:59\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2018.02.003","journal-title":"Cancer Lett"},{"issue":"1","key":"4180_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N et al (2020) Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun 11(1):2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1","journal-title":"Nat Commun"},{"issue":"4","key":"4180_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ccm.2011.08.003","volume":"32","author":"JE Larsen","year":"2011","unstructured":"Larsen JE, Minna JD (2011) Molecular biology of lung cancer: clinical implications. Clin Chest Med 32(4):703\u2013740. https:\/\/doi.org\/10.1016\/j.ccm.2011.08.003","journal-title":"Clin Chest Med"},{"issue":"1","key":"4180_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL et al (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"4180_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2024.07.004","author":"R Liu","year":"2025","unstructured":"Liu R et al (2025) Tumor-associated macrophages (TAMs): constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)\u2606. Cancer Pathog Therapy. https:\/\/doi.org\/10.1016\/j.cpt.2024.07.004","journal-title":"Cancer Pathog Therapy"},{"key":"4180_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.629941","volume":"9","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) Identification of a ceRNA network in lung adenocarcinoma based on integration analysis of tumor-associated macrophage signature genes. Front Cell Dev Biol 9:629941. https:\/\/doi.org\/10.3389\/fcell.2021.629941","journal-title":"Front Cell Dev Biol"},{"key":"4180_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622509","volume":"11","author":"W Jiang","year":"2021","unstructured":"Jiang W et al (2021) Exhausted CD8+ T cells in the tumor immune microenvironment: new pathways to therapy. Front Immunol 11:622509. https:\/\/doi.org\/10.3389\/fimmu.2020.622509","journal-title":"Front Immunol"},{"issue":"3","key":"4180_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Teng MW, Smyth MJ (2019) Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol 16(3):151\u2013167. https:\/\/doi.org\/10.1038\/s41571-018-0142-8","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4180_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/cancers13061188","volume":"13","author":"I-T Chyuan","year":"2021","unstructured":"Chyuan I-T, Chu C-L, Hsu P-N (2021) Targeting the tumor microenvironment for improving therapeutic effectiveness in cancer immunotherapy: focusing on immune checkpoint inhibitors and combination therapies. Cancers 13(6):1188. https:\/\/doi.org\/10.3390\/cancers13061188","journal-title":"Cancers"},{"issue":"1","key":"4180_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13694","volume":"17","author":"V Koroknai","year":"2024","unstructured":"Koroknai V et al (2024) Expression pattern of osteopontin isoforms in malignant melanoma cell lines. Clin Transl Sci 17(1):e13694. https:\/\/doi.org\/10.1111\/cts.13694","journal-title":"Clin Transl Sci"},{"issue":"12","key":"4180_CR13","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3390\/biomedicines11123178","volume":"11","author":"NP Kadoglou","year":"2023","unstructured":"Kadoglou NP et al (2023) The role of osteopontin in atherosclerosis and its clinical manifestations (atherosclerotic cardiovascular diseases)\u2014a narrative review. Biomedicines 11(12):3178. https:\/\/doi.org\/10.3390\/biomedicines11123178","journal-title":"Biomedicines"},{"issue":"44","key":"4180_CR14","doi-asserted-by":"publisher","first-page":"2400524","DOI":"10.1002\/advs.202400524","volume":"11","author":"L Dong","year":"2024","unstructured":"Dong L et al (2024) SPP1+ TAM regulates the metastatic colonization of CXCR4+ metastasis-associated tumor cells by remodeling the lymph node microenvironment. Adv Sci 11(44):2400524. https:\/\/doi.org\/10.1002\/advs.202400524","journal-title":"Adv Sci"},{"issue":"1","key":"4180_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12967-024-05613-w","volume":"22","author":"W Tong","year":"2024","unstructured":"Tong W et al (2024) Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment. J Transl Med 22(1):840. https:\/\/doi.org\/10.1186\/s12967-024-05613-w","journal-title":"J Transl Med"},{"issue":"1","key":"4180_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"2018","unstructured":"Benjamini Y, Hochberg Y (2018) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"1","key":"4180_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 19(1):9\u201331. https:\/\/doi.org\/10.1038\/s41568-018-0081-9","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4180_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A et al (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer 22(1):40. https:\/\/doi.org\/10.1186\/s12943-023-01740-y","journal-title":"Mol Cancer"},{"issue":"1","key":"4180_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13041-021-00886-4","volume":"14","author":"Y Xu","year":"2021","unstructured":"Xu Y et al (2021) Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases. Mol Brain 14(1):176. https:\/\/doi.org\/10.1186\/s13041-021-00886-4","journal-title":"Mol Brain"},{"issue":"7","key":"4180_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/neuonc\/noad017","volume":"25","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro-Oncol 25(7):1262\u20131274. https:\/\/doi.org\/10.1093\/neuonc\/noad017","journal-title":"Neuro-Oncol"},{"issue":"1","key":"4180_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00151-w","volume":"5","author":"T Jiang","year":"2021","unstructured":"Jiang T et al (2021) Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma. NPJ Precis Oncol 5(1):6. https:\/\/doi.org\/10.1038\/s41698-021-00151-w","journal-title":"NPJ Precis Oncol"},{"key":"4180_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27071","author":"X Wang","year":"2024","unstructured":"Wang X et al (2024) Single-cell RNA sequencing reveals distinct transcriptomic profiles and evolutionary patterns in lung cancer brain metastasis. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27071","journal-title":"Heliyon"},{"key":"4180_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fncel.2014.00362","volume":"8","author":"AC da Fonseca","year":"2014","unstructured":"da Fonseca AC et al (2014) The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 8:362. https:\/\/doi.org\/10.3389\/fncel.2014.00362","journal-title":"Front Cell Neurosci"},{"key":"4180_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109258","author":"Y Wu","year":"2024","unstructured":"Wu Y et al (2024) Single-cell RNA sequencing reveals epithelial cells driving brain metastasis in lung adenocarcinoma. iScience. https:\/\/doi.org\/10.1016\/j.isci.2024.109258","journal-title":"iScience"},{"key":"4180_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2019.05.004","volume":"50","author":"A Del Prete","year":"2019","unstructured":"Del Prete A et al (2019) Role of osteopontin in dendritic cell shaping of immune responses. Cytokine Growth Factor Rev 50:19\u201328. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.05.004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"4180_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cac2.12159","volume":"41","author":"SS Poh","year":"2021","unstructured":"Poh SS et al (2021) Retreatment in locally recurrent nasopharyngeal carcinoma: current status and perspectives. Cancer Commun 41(5):361. https:\/\/doi.org\/10.1002\/cac2.12159","journal-title":"Cancer Commun"},{"key":"4180_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184374","author":"E Matsubara","year":"2022","unstructured":"Matsubara E et al (2022) Spp1 derived from macrophages is associated with a worse clinical course and chemo-resistance in lung adenocarcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14184374","journal-title":"Cancers (Basel)"},{"key":"4180_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.phrs.2019.04.030","volume":"144","author":"X Pang","year":"2019","unstructured":"Pang X et al (2019) Osteopontin as a multifaceted driver of bone metastasis and drug resistance. Pharmacol Res 144:235\u2013244. https:\/\/doi.org\/10.1016\/j.phrs.2019.04.030","journal-title":"Pharmacol Res"},{"issue":"1","key":"4180_CR29","doi-asserted-by":"publisher","first-page":"8569575","DOI":"10.1155\/2021\/8569575","volume":"2021","author":"T Bie","year":"2021","unstructured":"Bie T, Zhang X (2021) Higher expression of SPP1 predicts poorer survival outcomes in head and neck cancer. J Immunol Res 2021(1):8569575. https:\/\/doi.org\/10.1155\/2021\/8569575","journal-title":"J Immunol Res"},{"issue":"4","key":"4180_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1011235","volume":"20","author":"L Xu","year":"2024","unstructured":"Xu L et al (2024) Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages. PLoS Genet 20(4):e1011235. https:\/\/doi.org\/10.1371\/journal.pgen.1011235","journal-title":"PLoS Genet"},{"issue":"9","key":"4180_CR31","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","volume":"15","author":"A-M Georgoudaki","year":"2016","unstructured":"Georgoudaki A-M et al (2016) Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep 15(9):2000\u20132011. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.084","journal-title":"Cell Rep"},{"key":"4180_CR32","doi-asserted-by":"publisher","first-page":"113944","DOI":"10.1016\/j.intimp.2024.113944","volume":"147","author":"Z Huang","year":"2025","unstructured":"Huang Z et al (2025) Spp1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma. Int Immunopharmacol 147:113944. https:\/\/doi.org\/10.1016\/j.intimp.2024.113944","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4180_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-023-04688-1","volume":"22","author":"Y Du","year":"2024","unstructured":"Du Y et al (2024) Potential crosstalk between SPP1+ TAMs and CD8+ exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer. J Transl Med 22(1):158. https:\/\/doi.org\/10.1186\/s12967-023-04688-1","journal-title":"J Transl Med"},{"key":"4180_CR34","doi-asserted-by":"publisher","first-page":"114906","DOI":"10.1016\/j.intimp.2025.114906","volume":"160","author":"L Hou","year":"2025","unstructured":"Hou L et al (2025) Targeting SPP1+ macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer. Int Immunopharmacol 160:114906. https:\/\/doi.org\/10.1016\/j.intimp.2025.114906","journal-title":"Int Immunopharmacol"},{"key":"4180_CR35","doi-asserted-by":"publisher","first-page":"646390","DOI":"10.3389\/fcell.2021.646390","volume":"9","author":"H Tang","year":"2021","unstructured":"Tang H et al (2021) Upregulation of SPP1 is a marker for poor lung cancer prognosis and contributes to cancer progression and cisplatin resistance. Front Cell Dev Biol 9:646390. https:\/\/doi.org\/10.3389\/fcell.2021.646390","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4180_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-023-04688-1","volume":"22","author":"Y Du","year":"2024","unstructured":"Du Y et al (2024) Potential crosstalk between SPP1 + TAMs and CD8 + exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer. J Transl Med 22(1):158. https:\/\/doi.org\/10.1186\/s12967-023-04688-1","journal-title":"J Transl Med"},{"issue":"12","key":"4180_CR37","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/jci123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement JD et al (2018) An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest 128(12):5549\u20135560. https:\/\/doi.org\/10.1172\/jci123360","journal-title":"J Clin Invest"},{"issue":"6","key":"4180_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00262-024-03689-3","volume":"73","author":"Q Lei","year":"2024","unstructured":"Lei Q et al (2024) A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis. Cancer Immunol Immunother 73(6):108. https:\/\/doi.org\/10.1007\/s00262-024-03689-3","journal-title":"Cancer Immunol Immunother"},{"issue":"8048","key":"4180_CR39","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","volume":"637","author":"A Lyu","year":"2025","unstructured":"Lyu A et al (2025) Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature 637(8048):1207\u20131217. https:\/\/doi.org\/10.1038\/s41586-024-08290-3","journal-title":"Nature"},{"issue":"1","key":"4180_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2350101","volume":"20","author":"X Xu","year":"2024","unstructured":"Xu X et al (2024) Spp1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma. Hum Vaccin Immunother 20(1):2350101. https:\/\/doi.org\/10.1080\/21645515.2024.2350101","journal-title":"Hum Vaccin Immunother"},{"key":"4180_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106791","author":"P Yuan","year":"2023","unstructured":"Yuan P et al (2023) Loss of AMPK\u03b12 promotes melanoma tumor growth and brain metastasis. iScience. https:\/\/doi.org\/10.1016\/j.isci.2023.106791","journal-title":"iScience"},{"key":"4180_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216508","volume":"581","author":"S Wu","year":"2024","unstructured":"Wu S et al (2024) A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Lett 581:216508. https:\/\/doi.org\/10.1016\/j.canlet.2023.216508","journal-title":"Cancer Lett"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04180-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:04:34Z","timestamp":1760961874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04180-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4180"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04180-3","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University, China, Ethics approval number: (2024-KY-0618\u2013004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"319"}}